Roles
- Associate Professor of Dermatology and Cutaneous Surgery
-
Education & Training
Education
Licensures and Certifications
-
Honors & Awards
-
Research Interests
Dr. Tang's major interest in cancer research is high risk cutaneous squamous cell carcinoma. She is interested in the small subset (< 5%) of patients with poor prognosis including metastasis and mortality. There are evolving criteria for high risk tumors and no consensus on management. Dr. Tang wants to close this practice gap in determining appropriate treatment guidelines. -
Publications
Disclaimer: Information presented in this section has been consolidated using AI and machine learning technologies. While every effort has been made to ensure accuracy, errors may occur. If you identify any inaccuracies, use this link to inform our data team. Your feedback is appreciated and helps us improve the quality of our content.
Clinical Trials
Viewing 0 of 2 clinical trials.
-
An Open-Label, Multicenter, Phase 1B/2 Study of RP1 in Solid Organ and Hematopoietic Cell Transplant Recipients With Advanced Cutaneous Malignancies
- Principal Investigator: Jennifer Tang
- Study Phase: Phase 1/Phase 2
- Enrollment Status: Closed
-
A Phase II Study of Talimogene Laherparepvec Followed by Talimogene Laherparepvec + Nivolumab in Refractory T Cell and NK Cell Lymphomas, Cutaneous Squamous Cell Carcinoma, Merkel Cell Carcinoma, and Other Rare Skin Tumors
- Principal Investigator: Jennifer Tang
- Study Phase: Phase 2
- Enrollment Status: Closed
